(Q40623119)

22 September 2017

Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets (English)

1 reference

22 September 2017

Rapamycin Has a Deleterious Effect on MIN-6 Cells and Rat and Human Islets (English)

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

25 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

25 March 2024

author name string

Ewan Bell

1

1 reference

22 September 2017

Xiaopei Cao

2

1 reference

22 September 2017

Robert Young

5

1 reference

22 September 2017

Matteo Trucco

6

1 reference

22 September 2017

Zhiyong Gao

7

1 reference

22 September 2017

Shaoping Deng

9

1 reference

22 September 2017

Ali Naji

11

1 reference

22 September 2017

Jacob A. Moibi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578291

25 March 2024

Scott R. Greene

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578291

25 March 2024

Franz M. Matschinsky

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578291

25 March 2024

James F. Markman

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578291

25 March 2024

Bryan A. Wolf

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578291

25 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

22 September 2017

https://diabetesjournals.org/diabetes/article-pdf/52/11/2731/372350/db1103002731.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578291

https://journals.org/diabetes/diabetes/article-pdf/52/11/2731/372350/db1103002731.pdf

25 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

https://diabetesjournals.org/diabetes/article-pdf/52/11/2731/372350/db1103002731.pdf

25 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

25 March 2024

1 reference

22 September 2017

52

1 reference

22 September 2017

11

1 reference

22 September 2017

2731-2739

1 reference

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

22 September 2017

1

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function

25 March 2024

2

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection

25 March 2024

3

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus

25 March 2024

4

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Rescue therapy: a role for sirolimus in lung and heart transplant recipients

25 March 2024

5

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up

25 March 2024

6

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model

25 March 2024

7

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation

25 March 2024

8

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

25 March 2024

9

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

25 March 2024

10

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin

25 March 2024

12

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells

25 March 2024

13

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages

25 March 2024

16

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).

25 March 2024

17

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD

25 March 2024

18

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation

25 March 2024

19

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients.

25 March 2024

21

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets

25 March 2024

23

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

16 A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of langerhans

25 March 2024

24

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Synaptotagmin III/VII isoforms mediate Ca2+-induced insulin secretion in pancreatic islet beta -cells

25 March 2024

25

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Advances in therapeutic drug monitoring for immunosuppressants: a review of sirolimus. Introduction and overview

25 March 2024

26

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

Portal vein immunosuppressant levels and islet graft toxicity

25 March 2024

27

1 reference

https://api.crossref.org/works/10.2337/DIABETES.52.11.2731

25 March 2024

Identifiers

1 reference

22 September 2017

1 reference